Noninvasive assessment of ectopic uterine tissue development in rats using magnetic resonance imaging

Fertility and Sterility

Volumn 88, Issue 4 SUPPL., 2007, Pages 1058-1064

  Lenhard, Stephen C ^a   Haimbach, Robin E ^a   Sulpizio, Anthony C ^a   Brooks, David P ^a   Bray, Jeffrey D ^a   Jucker, Beat M ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

ectopic uterine tissue; Endometriosis; estrous cycle; magnetic resonance imaging; rat

Indexed keywords

ESTRADIOL; GADOLINIUM PENTETATE; ITURELIX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ECTOPIC TISSUE; ENDOMETRIOSIS; ESTRUS CYCLE; FEMALE; HORMONAL THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIECTOMY; PERITONEUM; PRIORITY JOURNAL; RAT; TISSUE PERFUSION; TRANSPLANTATION; UTERUS;

ANIMALS; CHORISTOMA; ENDOMETRIOSIS; ESTROUS CYCLE; FEMALE; MAGNETIC RESONANCE IMAGING; PERITONEAL CAVITY; RATS; RATS, SPRAGUE-DAWLEY; UTERUS;

EID: 34848921121     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.11.164     Document Type: Article

References (27)

1. Hastings J., and Fazleabas A. Future directions in endometriosis research. Sem Rep Med 21 (2003) 255-262
2. Brosens J., Timmerman D., Starzinski-Powitz A., and Brosens I. Noninvasive diagnosis of endometriosis: the role of imaging and markers. Obstet Gynecol Clin N Am 30 (2003) 95-114
3. Frackiewicz E., and Zarotsky V. Diagnosis and treatment of endometriosis. Expert Opin Pharmacother 4 (2003) 67-82
4. Vercellini P., Trespidi L., Colombo A., Vendola N., Marchini M., and Crosignani P. A gonadotropin-releasing hormone agonist versus a low does oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril 60 (1993) 75-79
5. Muneyyirci-Delale O., and Karacan M. Effect of norethindrone acetate in the treatment of symptomatic endometriosis. Int J Fertil Womens Med 43 (1998) 24-27
6. Tjaden B., Galetto D., Woodruff J., and Rock J. Time-related effects of RU486 treatment in experimentally induced endometriosis in the rat. Fertil Steril 59 (1993) 437
7. Kettel L., Murphy A., Morales A., Ulmann A., Baulien E., and Yen S. Treatment of endometriosis with the antiprogestin mifepristone (RU486). Fertil Steril 65 (1996) 23-28
8. Adamson G., Kwei L., and Edgren R. Pain of endometriosis: effects of nafarelin and danazol therapy. Int J Fertil Menopausal Stud 39 (1994) 215-217
9. Dawood M., Ramos J., and Khan-Dawood F. Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin. Fertil Steril 63 (1995) 1177-1183
10. Sagsveen M., Farmer J., Prentice A., and Breeze A. Gonadotropin-releasing hormone analogues for endometriosis: bone mineral density. Cochrane Database Syst Rev 4 (2003) CD001297
11. Miller J. Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: a double blind, randomized placebo-controlled trial. Am J Obstet Gynecol 182 (2000) 1483-1488
12. Tahara M., Matsuoka T., Yokoi T., Tasaka K., and Murata Y. Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low dose agonist therapy. Fertil Steril 73 (2000) 799-804
13. Takeuchi H., Kobori H., Kikuchi I., Sato Y., and Mitsuhashi N. A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonsists in cases of uterine leiomyomas or endometriosis. J Obstet Gynaecol Res 26 (2000) 325-331
14. Vercellini P., Crosignani P., Fadini R., Radici E., Belloni C., and Sismondi P. A gonadotropin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. Br J Obstet Gynaecol 106 (1999) 672-677
15. Olive D., and Pritts E. Treatment of endometriosis. N Engl J Med 345 (2001) 266-275
16. Story L., and Kennedy S. Animal studies in endometriosis: a review. ILAR J 45 (2004) 132-138
17. Fortin M., Lepine M., Page M., Osteen K., Massie B., Hugo P., et al. An improved mouse model for endometriosis allows noninvasive assessment of lesion implantation and development. Fertil Steril 80 (2003) 832-838
18. Fortin M., Lepine M., Merlen Y., Thibeault I., Rancourt C., Gosselin D., et al. Quantitative assessment of human endometriotic tissue maintenance and regression in a noninvasive mouse model of endometriosis. Mol Ther 9 (2004) 540-547
19. Hirata T., Osuga Y., Yoshino O., Hirota Y., Harada M., Takemura Y., et al. Development of an experimental model of endometriosis using mice that ubiquitously express green fluorescent protein. Hum Reprod 20 (2005) 2092-2096
20. Jones R. The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy- 40,972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat. Acta Endocrinol 106 (1984) 282-288
21. Tamborini P., Sigg H., and Zbinden G. Quantitative analysis of rat activity in the home cage by infrared monitoring. Application to the acute toxicity testing of acetanilide and phenylmercuric acetate. Arch Toxicol 63 (1989) 85-96
22. Vernon M., and Wilson E. Studies on the surgical induction of endometriosis in the rat. Fertil Steril 44 (1985) 684-694
23. Stratton P., Winkel C., Premkumar A., Chow C., Wilson J., Hearns-Stokes R., et al. Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis. Fertil Steril 79 (2003) 1078-1085
24. Umaria N., and Olliff J. Imaging features of pelvic endometriosis. Brit J Radiol 74 (2001) 556-562
25. Sharpe-Timms K. Using rats as a research model for the study of endometriosis. Ann NY Acad Sci 955 (2002) 318-327
26. Sharpe K., Bertero M., Muse K., and Vernon M. Spontaneous and steroid-induced recurrence of endometriosis after suppression by a gonadotropin-releasing hormone antagonist in the rat. Am J Obstet Gynecol 64 (1991) 187-194
27. Nap A., Griffioen A., Dunselman G., Bouma-ter Steege J., Thijssen V., Evers J., et al. Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab 89 (2004) 1089-1095